Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Sep 28, 2006

BioNanoMatrix Receives Grant to Speed Development of Nanoscale Whole-Genome Analyzer

  • BioNanomatrix received a grant from the The National Human Genome Research Institute (NHGRI) to support development of its nanoscale platform for genomic analysis. The two-year, $397,750 SBIR grant was awarded under the NIH BioEngineering Nanotechnology Initiative.

    “The nanochannel array technology we are developing with this funding is designed to permit direct visualization and analysis of multimegabase fragments of DNA at the single-molecule level with high feature resolution, allowing researchers to visualize mutations, haplotypes, epigenetic features, and even DNA-protein binding events,” explains Han Cao, Ph.D., CSO and principal investigator on this grant.

    BioNanomatrix is developing integrated systems that enable nanoscale, single-molecule identification and analysis of the entire genome, delivering single-molecule sensitivity with haplotyping capability in a highly parallel format. The company’s analytic platform, based on this technology provides ultrahigh-resolution analyses of DNA, RNA, and other proteins.


GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Pharmacists and Prescription Drug Misuse Programs

Do you agree that pharmacists should make a greater effort to become more involved with prescription drug-monitoring programs?

More »